Norie Murayama
- Pharmacology top 0.02%
- Pharmacogenetics and Drug Metabolism 176
- Drug-Induced Hepatotoxicity and Protection 31
- Inflammatory mediators and NSAID effects 16
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology 24
- Oncology top 2%
- Drug Transport and Resistance Mechanisms 93
-
- Hormonal Regulation and Hypertension 17
- Transplantation top 5%
-
- Computational Drug Discovery Methods 27
-
- Carcinogens and Genotoxicity Assessment 17
- Co-authors
- Hiroshi YamazakiYasushi YamazoeMakiko ShimizuYasuhiro UnoToshiro NiwaMiki ShimadaShotaro UeharaF. Peter Guengerich
- Cited by
- PharmacologyBiochemistryOncology
- Journals
- Journal of Biological Chemistry (1 paper)PLoS ONE (3 papers)Biochemical and Biophysical Research Communications (3 papers)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Norie Murayama
231 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 126
- Pharmacology 3.1k
- Biochemistry 512
- Oncology 1.6k
- Endocrinology, Diabetes and Metabolism 679
- Transplantation 84
Countries citing papers authored by Norie Murayama
This map shows the geographic impact of Norie Murayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norie Murayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norie Murayama more than expected).
Fields of papers citing papers by Norie Murayama
This network shows the impact of papers produced by Norie Murayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norie Murayama. The network helps show where Norie Murayama may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Norie Murayama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 9 | |
| 6 | 2022 | 13 | |
| 7 | 2020 | 8 | |
| 8 | 2015 | 21 | |
| 9 | 2014 | 31 | |
| 10 | 2014 | 14 | |
| 11 | 2013 | 12 | |
| 12 | 2012 | 18 | |
| 13 | 2011 | 17 | |
| 14 | 2011 | 13 | |
| 15 | 2010 | 13 | |
| 16 | 2006 | 25 | |
| 17 | 2004 | 71 | |
| 18 | 2003 | 57 | |
| 19 | 2000 | 26 | |
| 20 | 1990 | 41 |
About Norie Murayama
Norie Murayama is a scholar working on Pharmacology, Biochemistry and Oncology, having authored 235 papers that have together received 5.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (176 papers), Drug Transport and Resistance Mechanisms (93 papers), Drug-Induced Hepatotoxicity and Protection (31 papers), Computational Drug Discovery Methods (27 papers), Eicosanoids and Hypertension Pharmacology (24 papers), Hormonal Regulation and Hypertension (17 papers), Carcinogens and Genotoxicity Assessment (17 papers) and Inflammatory mediators and NSAID effects (16 papers). The work is most often cited by research in Pharmacology (3.1k citations), Biochemistry (512 citations) and Oncology (1.6k citations). Norie Murayama has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Hiroshi Yamazaki, Yasushi Yamazoe, Makiko Shimizu, Yasuhiro Uno, Toshiro Niwa, Miki Shimada, Shotaro Uehara, F. Peter Guengerich, Ritsushi Kato and Ryuichi Kato. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.